Drzezga A - Search Results

1

Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's disease.

Myers N, Pasquini L, Göttler J, Grimmer T, Koch K, Ortner M, Neitzel J, Mühlau M, Förster S, Kurz A, Förstl H, Zimmer C, Wohlschläger AM, Riedl V, Drzezga A, Sorg C. Myers N, et al. Among authors: drzezga a. Brain. 2014 Jul;137(Pt 7):2052-64. doi: 10.1093/brain/awu103. Epub 2014 Apr 26. Brain. 2014. PMID: 24771519 Free PMC article.

2

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M. Ishii K, et al. Among authors: drzezga a. J Nucl Med. 2001 Apr;42(4):548-57. J Nucl Med. 2001. PMID: 11337540 Free article.

3

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.

Lautenschlager NT, Riemenschneider M, Drzezga A, Kurz AF. Lautenschlager NT, et al. Among authors: drzezga a. Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):379-86. doi: 10.1159/000051284. Dement Geriatr Cogn Disord. 2001. PMID: 11598309

4

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B, Drzezga A, Jahn T, Förstl H, Kurz A. Riemenschneider M, et al. Among authors: drzezga a. Neurology. 2002 Jun 11;58(11):1622-8. doi: 10.1212/wnl.58.11.1622. Neurology. 2002. PMID: 12058089

5

Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia.

Drzezga A, Grimmer T, Siebner H, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. J Neurol. 2002 Sep;249(9):1263-7. doi: 10.1007/s00415-002-0832-z. J Neurol. 2002. PMID: 12242551

6

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A. Riemenschneider M, et al. Among authors: drzezga a. Arch Neurol. 2002 Nov;59(11):1729-34. doi: 10.1001/archneur.59.11.1729. Arch Neurol. 2002. PMID: 12433260

7

The role of biological markers in the early and differential diagnosis of Alzheimer's disease.

Kurz A, Riemenschneider M, Drzezga A, Lautenschlager N. Kurz A, et al. Among authors: drzezga a. J Neural Transm Suppl. 2002;(62):127-33. doi: 10.1007/978-3-7091-6139-5_13. J Neural Transm Suppl. 2002. PMID: 12456058 Review.

8

PET in patients with clear-cut multiple chemical sensitivity (MCS).

Bornschein S, Hausteiner C, Drzezga A, Bartenstein P, Schwaiger M, Förstl H, Zilker T. Bornschein S, et al. Among authors: drzezga a. Nuklearmedizin. 2002 Dec;41(6):233-9. Nuklearmedizin. 2002. PMID: 12520659

9

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 12764551 Clinical Trial.

10

Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study.

Grimmer T, Diehl J, Drzezga A, Förstl H, Kurz A. Grimmer T, et al. Among authors: drzezga a. Dement Geriatr Cogn Disord. 2004;18(1):32-6. doi: 10.1159/000077732. Epub 2004 Apr 6. Dement Geriatr Cogn Disord. 2004. PMID: 15084791 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page